Time-of-Day Immunotherapy Administration and Outcomes in Advanced Cancers: A Systematic Review and - Poll - MDSpire

Time-of-Day Immunotherapy Administration and Outcomes in Advanced Cancers: A Systematic Review and

  • By

  • Shota Inoue

  • Ichiro Tsuboi

  • Marcin Miszczyk

  • Keiichiro Miyajima

  • Navid Roessler

  • Ahmed R. Alfarhan

  • Satoshi Katayama

  • Pierre I. Karakiewicz

  • Motoo Araki

  • Shahrokh F. Shariat

  • May 5, 2026

  • 0 min

Share

Original Source(s)

Time-of-Day Immunotherapy Administration and Outcomes in Advanced Cancers: A Systematic Review and

  • by Shota Inoue, Ichiro Tsuboi, Marcin Miszczyk, Keiichiro Miyajima, Navid Roessler, Ahmed R. Alfarhan, Satoshi Katayama, Pierre I. Karakiewicz, Motoo Araki, Shahrokh F. Shariat

  • May 5, 2026

Related Content

Impact of the clonal architecture and probable biallelic inactivation of TET2 mutations in myelodysplastic neoplasms

Recurrent pleuropulmonary blastoma type III initially misclassified as embryonal rhabdomyosarcoma on limited biopsy: a case report with pathogenic DICER1 variant

Case Report: First description of an intracranial “NET” in ROHHAD syndrome; time to rename to the ROHHAD-NeCT syndrome?